콘텐츠로 건너뛰기
Merck
  • Failure of the biguanide moroxydine chloride to stimulate plasma fibrinolytic activity.

Failure of the biguanide moroxydine chloride to stimulate plasma fibrinolytic activity.

Acta medica Scandinavica (1984-01-01)
M Boberg, A Killander
초록

Eleven patients with recurrent venous thrombosis or thrombophlebitis and a decreased fibrinolytic activity after venous occlusion were given a phenformin-like substance, moroxydine chloride, for 6 months. No sustained increase in the fibrinolytic activity was observed after moroxydine treatment.

MATERIALS
제품 번호
브랜드
제품 설명

Sigma-Aldrich
Moroxydine hydrochloride, 99%